Trgovina Teva Pharma Ind Adr Rep 1 - TEVA CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.07 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Teva Pharmaceutical Industries Ltd ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Ključni statistični podatki
| Predhodno. Zapri* | 7.19 |
| Odpri* | 7.18 |
| Enoletna sprememba* | -22.13% |
| Dnevni razpon* | 7.12 - 7.18 |
| Razpon 52 wk | 6.78-11.45 |
| Povprečni obseg (10 dni) | 21.62M |
| Povprečni obseg (3 meseci) | 261.98M |
| Tržna kapitalizacija | 8.23B |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 1.12B |
| Prihodki | 14.93B |
| EPS | -1.44 |
| Dividenda (donosnost v %) | N/A |
| Beta | 1.18 |
| Datum naslednjega zaslužka | Jul 25, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| Jun 5, 2023 | 7.18 | -0.01 | -0.14% | 7.19 | 7.21 | 7.11 |
| Jun 2, 2023 | 7.19 | -0.02 | -0.28% | 7.21 | 7.23 | 7.09 |
| Jun 1, 2023 | 7.16 | -0.04 | -0.56% | 7.20 | 7.25 | 7.14 |
| May 31, 2023 | 7.20 | 0.13 | 1.84% | 7.07 | 7.24 | 7.05 |
| May 30, 2023 | 7.16 | -0.30 | -4.02% | 7.46 | 7.46 | 7.16 |
| May 26, 2023 | 7.41 | 0.12 | 1.65% | 7.29 | 7.46 | 7.29 |
| May 25, 2023 | 7.29 | -0.14 | -1.88% | 7.43 | 7.44 | 7.22 |
| May 24, 2023 | 7.54 | -0.07 | -0.92% | 7.61 | 7.61 | 7.47 |
| May 23, 2023 | 7.65 | -0.23 | -2.92% | 7.88 | 7.93 | 7.65 |
| May 22, 2023 | 7.91 | -0.10 | -1.25% | 8.01 | 8.02 | 7.84 |
| May 19, 2023 | 7.87 | -0.36 | -4.37% | 8.23 | 8.24 | 7.86 |
| May 18, 2023 | 8.20 | -0.22 | -2.61% | 8.42 | 8.72 | 8.19 |
| May 17, 2023 | 8.09 | -0.07 | -0.86% | 8.16 | 8.16 | 7.96 |
| May 16, 2023 | 8.10 | 0.12 | 1.50% | 7.98 | 8.14 | 7.98 |
| May 15, 2023 | 8.03 | 0.04 | 0.50% | 7.99 | 8.14 | 7.98 |
| May 12, 2023 | 8.00 | -0.07 | -0.87% | 8.07 | 8.15 | 7.88 |
| May 11, 2023 | 8.17 | -0.20 | -2.39% | 8.37 | 8.37 | 8.08 |
| May 10, 2023 | 8.32 | 0.04 | 0.48% | 8.28 | 8.47 | 7.98 |
| May 9, 2023 | 9.07 | 0.08 | 0.89% | 8.99 | 9.17 | 8.93 |
| May 8, 2023 | 9.01 | 0.24 | 2.74% | 8.77 | 9.05 | 8.77 |
Teva Pharma Ind Adr Rep 1 Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Skupni prihodki | 14925 | 15878 | 16659 | 16887 | 18854 |
| Prihodki | 14925 | 15878 | 16659 | 16887 | 18854 |
| Celotni stroški prihodkov | 7487 | 8014 | 8870 | 9351 | 10558 |
| Bruto dobiček | 7438 | 7864 | 7789 | 7536 | 8296 |
| Celotni odhodki iz poslovanja | 17024 | 14162 | 20231 | 17330 | 20537 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 3445 | 3402 | 3519 | 3667 | 4052 |
| Raziskave in razvoj | 838 | 967 | 997 | 1010 | 1213 |
| Nenavadni odhodki (prihodki) | 5239 | 1721 | 6739 | 3191 | 4838 |
| Other Operating Expenses, Total | 15 | -41 | -20 | -28 | -286 |
| Prihodki iz poslovanja | -2099 | 1716 | -3572 | -443 | -1683 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -904 | -988 | -833 | -825 | -894 |
| Drugo, neto | -62 | -70 | -1 | 3 | -19 |
| Čisti dobiček pred obdavčitvijo | -3065 | 658 | -4406 | -1265 | -2596 |
| Čisti dobiček po davkih | -2427 | 447 | -4238 | -987 | -2304 |
| Manjšinski delež | 53 | -39 | 109 | 2 | 322 |
| Equity In Affiliates | 21 | 9 | 138 | -13 | -71 |
| Čisti dobiček pred dodatnimi postavkami | -2353 | 417 | -3991 | -998 | -2053 |
| Skupaj izredne postavke | 0 | 0 | -97 | ||
| Čisti dobiček | -2353 | 417 | -3991 | -998 | -2150 |
| Total Adjustments to Net Income | 1 | -1 | -249 | ||
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -2353 | 417 | -3990 | -999 | -2302 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -2353 | 417 | -3990 | -999 | -2399 |
| Prilagoditev za redčenje | |||||
| Popravljen čisti dobiček | -2353 | 417 | -3990 | -999 | -2399 |
| Popravljene ponderirane povprečne delnice | 1110 | 1107 | 1095 | 1091 | 1021 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -2.11982 | 0.37669 | -3.64384 | -0.91567 | -2.25465 |
| Dividends per Share - Common Stock Primary Issue | 0 | ||||
| Popravljen normalizirani dobiček na enoto čistega dobička | 0.94806 | 1.43282 | 0.35648 | 0.98547 | 0.82537 |
| Depreciation / Amortization | 99 | 126 | 139 | 162 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Skupni prihodki | 3661 | 3884 | 3595 | 3786 | 3661 |
| Prihodki | 3661 | 3884 | 3595 | 3786 | 3661 |
| Celotni stroški prihodkov | 2015 | 1784 | 1885 | 1958 | 1859 |
| Bruto dobiček | 1646 | 2100 | 1710 | 1828 | 1802 |
| Celotni odhodki iz poslovanja | 3659 | 4739 | 3176 | 4735 | 4374 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 842 | 837 | 777 | 849 | 819 |
| Raziskave in razvoj | 234 | 210 | 175 | 228 | 225 |
| Depreciation / Amortization | 20 | 21 | 22 | ||
| Nenavadni odhodki (prihodki) | 561 | 1854 | 321 | 1683 | 1502 |
| Other Operating Expenses, Total | 7 | 54 | -2 | -4 | -53 |
| Prihodki iz poslovanja | 2 | -855 | 419 | -949 | -713 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -260 | -237 | -230 | -225 | -238 |
| Drugo, neto | -9 | -23 | 14 | -20 | |
| Čisti dobiček pred obdavčitvijo | -258 | -1101 | 166 | -1160 | -971 |
| Čisti dobiček po davkih | -239 | -1255 | 59 | -260 | -973 |
| Manjšinski delež | 33 | 32 | -3 | 27 | -3 |
| Equity In Affiliates | 1 | -1 | 0 | 21 | |
| Čisti dobiček pred dodatnimi postavkami | -206 | -1222 | 55 | -233 | -955 |
| Čisti dobiček | -206 | -1222 | 55 | -233 | -955 |
| Total Adjustments to Net Income | 1 | 1 | 1 | 1 | |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -205 | -1221 | 56 | -232 | -955 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -205 | -1221 | 56 | -232 | -955 |
| Popravljen čisti dobiček | -205 | -1221 | 56 | -232 | -955 |
| Popravljene ponderirane povprečne delnice | 1115 | 1113 | 1119 | 1110 | 1107 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.18386 | -1.09704 | 0.05004 | -0.20901 | -0.86269 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | 0.17641 | -0.01429 | 0.23651 | 0.77653 | 0.01924 |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 12051 | 12573 | 13005 | 13464 | 13794 |
| Denarna sredstva in kratkoročne naložbe | 2801 | 2165 | 2177 | 1975 | 1784 |
| Denarna sredstva in ustrezniki | 2801 | 2165 | 2177 | 1975 | 1782 |
| Kratkoročne naložbe | 2 | ||||
| Celotne terjatve, neto | 3696 | 4529 | 4581 | 5676 | 5822 |
| Accounts Receivable - Trade, Net | 3696 | 4529 | 4581 | 5676 | 5822 |
| Total Inventory | 3833 | 3818 | 4403 | 4422 | 4731 |
| Prepaid Expenses | 1162 | 1075 | 945 | 870 | 899 |
| Other Current Assets, Total | 559 | 986 | 899 | 521 | 558 |
| Total Assets | 44006 | 47666 | 50640 | 57470 | 60683 |
| Property/Plant/Equipment, Total - Net | 6158 | 6477 | 6855 | 6950 | 6868 |
| Property/Plant/Equipment, Total - Gross | 11676 | 11718 | 11947 | 11864 | 11796 |
| Accumulated Depreciation, Total | -5518 | -5241 | -5092 | -4914 | -4928 |
| Goodwill, Net | 17633 | 20040 | 20624 | 24846 | 24917 |
| Intangibles, Net | 6270 | 7466 | 8923 | 11232 | 14005 |
| Other Long Term Assets, Total | 1894 | 1110 | 1233 | 978 | 1038 |
| Total Current Liabilities | 11469 | 11027 | 13164 | 13674 | 14322 |
| Accounts Payable | 1887 | 1686 | 1756 | 1718 | 1853 |
| Accrued Expenses | 2810 | 2880 | 2581 | 2680 | 2738 |
| Notes Payable/Short Term Debt | 23 | 23 | 514 | 514 | 516 |
| Current Port. of LT Debt/Capital Leases | 2086 | 1403 | 2674 | 1831 | 1700 |
| Other Current Liabilities, Total | 4663 | 5035 | 5639 | 6931 | 7515 |
| Total Liabilities | 36109 | 37388 | 40614 | 43498 | 45976 |
| Total Long Term Debt | 19103 | 21617 | 22731 | 24562 | 26691 |
| Long Term Debt | 19103 | 21617 | 22731 | 24562 | 26691 |
| Deferred Income Tax | 548 | 784 | 964 | 1096 | 2140 |
| Minority Interest | 794 | 966 | 1035 | 1091 | 1087 |
| Other Liabilities, Total | 4195 | 2994 | 2720 | 3075 | 1736 |
| Total Equity | 7897 | 10278 | 10026 | 13972 | 14707 |
| Redeemable Preferred Stock | 0 | ||||
| Common Stock | 57 | 57 | 57 | 56 | 56 |
| Additional Paid-In Capital | 27688 | 27561 | 27443 | 27312 | 27210 |
| Retained Earnings (Accumulated Deficit) | -12882 | -10529 | -10946 | -6956 | -5958 |
| Treasury Stock - Common | -4128 | -4128 | -4128 | -4128 | -4142 |
| Unrealized Gain (Loss) | 0 | 0 | 0 | 1 | |
| Other Equity, Total | -2838 | -2683 | -2400 | -2312 | -2460 |
| Total Liabilities & Shareholders’ Equity | 44006 | 47666 | 50640 | 57470 | 60683 |
| Total Common Shares Outstanding | 1110.9 | 1103.33 | 1096.51 | 1092.19 | 1089.39 |
| Total Preferred Shares Outstanding | 0 | 0 | 0 | ||
| Long Term Investments | 61 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 11501 | 12051 | 11453 | 12164 | 12451 |
| Denarna sredstva in kratkoročne naložbe | 2143 | 2801 | 2225 | 2058 | 2175 |
| Denarna sredstva in ustrezniki | 2143 | 2801 | 2225 | 2058 | 2175 |
| Celotne terjatve, neto | 3435 | 3696 | 3730 | 4471 | 4253 |
| Accounts Receivable - Trade, Net | 3435 | 3696 | 3730 | 4471 | 4253 |
| Total Inventory | 4118 | 3833 | 3859 | 4049 | 4012 |
| Prepaid Expenses | 1253 | 1162 | 1045 | 1052 | 1064 |
| Other Current Assets, Total | 552 | 559 | 594 | 534 | 947 |
| Total Assets | 43456 | 44006 | 44252 | 45932 | 47059 |
| Property/Plant/Equipment, Total - Net | 6171 | 6158 | 5990 | 6181 | 6396 |
| Goodwill, Net | 17799 | 17633 | 18433 | 18837 | 19986 |
| Intangibles, Net | 5964 | 6270 | 6393 | 6700 | 7116 |
| Other Long Term Assets, Total | 2021 | 1894 | 1983 | 2050 | 1110 |
| Total Current Liabilities | 10411 | 11469 | 11534 | 10996 | 11613 |
| Accounts Payable | 2381 | 1887 | 1635 | 1901 | 1750 |
| Accrued Expenses | 2699 | 2717 | 2537 | 2579 | 3078 |
| Notes Payable/Short Term Debt | 23 | 23 | 23 | 23 | 23 |
| Current Port. of LT Debt/Capital Leases | 1000 | 2086 | 2746 | 1696 | 2054 |
| Other Current Liabilities, Total | 4308 | 4756 | 4593 | 4797 | 4708 |
| Total Liabilities | 35595 | 36109 | 35484 | 36895 | 37715 |
| Total Long Term Debt | 19668 | 19103 | 18497 | 20363 | 20840 |
| Long Term Debt | 19668 | 19103 | 18497 | 20363 | 20840 |
| Deferred Income Tax | 550 | 548 | 503 | 532 | 666 |
| Minority Interest | 751 | 794 | 751 | 791 | 916 |
| Other Liabilities, Total | 4215 | 4195 | 4199 | 4213 | 3680 |
| Total Equity | 7861 | 7897 | 8768 | 9037 | 9344 |
| Common Stock | 57 | 57 | 57 | 57 | 57 |
| Additional Paid-In Capital | 27719 | 27688 | 27652 | 27625 | 27587 |
| Retained Earnings (Accumulated Deficit) | -13086 | -12882 | -11660 | -11716 | -11484 |
| Treasury Stock - Common | -4128 | -4128 | -4128 | -4128 | -4128 |
| Other Equity, Total | -2701 | -2838 | -3153 | -2801 | -2688 |
| Total Liabilities & Shareholders’ Equity | 43456 | 44006 | 44252 | 45932 | 47059 |
| Total Common Shares Outstanding | 1120.41 | 1110.9 | 1110.64 | 1110.56 | 1110.35 |
| Total Preferred Shares Outstanding | |||||
| Unrealized Gain (Loss) |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -2406 | 456 | -4099 | -1000 | -2472 |
| Denarna sredstva iz poslovanja | 1590 | 798 | 1216 | 748 | 2446 |
| Denarna sredstva iz poslovanja | 1308 | 1330 | 1557 | 1722 | 1842 |
| Deferred Taxes | -1059 | -120 | -696 | -985 | -837 |
| Nedenarne postavke | 2490 | 833 | 6642 | 1907 | 5736 |
| Cash Taxes Paid | 543 | 495 | 709 | 552 | 420 |
| Denarna sredstva Plačane obresti | 948 | 913 | 846 | 840 | 815 |
| Spremembe v obratnem kapitalu | 1257 | -1701 | -2188 | -896 | -1823 |
| Denarna sredstva pri naložbenju | 656 | 1523 | 863 | 1355 | 1866 |
| Kapitalski izdatki | -548 | -562 | -578 | -525 | -651 |
| Celotne druge postavke denarnih tokov pri naložbenju | 1204 | 2085 | 1441 | 1880 | 2517 |
| Denarna sredstva pri financiranju | -1487 | -2172 | -1885 | -1926 | -3351 |
| Postavke denarnega toka pri financiranju | -118 | -6 | -5 | -11 | -57 |
| Total Cash Dividends Paid | 0 | 0 | -52 | -22 | |
| Izdaja (odplačilo) delnic, neto | 0 | ||||
| Izdaja (odplačilo) dolga, neto | -1369 | -2166 | -1880 | -1863 | -3272 |
| Učinki deviznih tečajev | -123 | -128 | 8 | 16 | -142 |
| Neto sprememba denarnih sredstev | 636 | 21 | 202 | 193 | 819 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -238 | -2406 | -1152 | -1211 | -952 |
| Cash From Operating Activities | -145 | 1590 | 617 | 73 | -49 |
| Cash From Operating Activities | 304 | 1308 | 1002 | 681 | 323 |
| Deferred Taxes | -106 | -1059 | -1214 | -1258 | -175 |
| Non-Cash Items | 259 | 2490 | 974 | 949 | 196 |
| Changes in Working Capital | -364 | 1257 | 1007 | 912 | 559 |
| Cash From Investing Activities | 181 | 656 | 488 | 341 | 161 |
| Capital Expenditures | -139 | -548 | -406 | -284 | -157 |
| Other Investing Cash Flow Items, Total | 320 | 1204 | 894 | 625 | 318 |
| Cash From Financing Activities | -706 | -1487 | -776 | -336 | 2 |
| Financing Cash Flow Items | -5 | -118 | -115 | -40 | 2 |
| Issuance (Retirement) of Debt, Net | -701 | -1369 | -661 | -296 | 0 |
| Foreign Exchange Effects | 12 | -123 | -269 | -185 | -62 |
| Net Change in Cash | -658 | 636 | 60 | -107 | 52 |
| Total Cash Dividends Paid |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| Capital Research Global Investors | Investment Advisor | 7.3765 | 82644367 | -32149622 | 2023-03-31 | LOW |
| Capital World Investors | Investment Advisor | 4.5199 | 50639163 | 75176 | 2023-03-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.7297 | 30582654 | -54180 | 2023-03-31 | LOW |
| Ion Asset Management Israel Ltd | Hedge Fund | 2.5162 | 28190724 | 22993331 | 2023-03-31 | MED |
| Menora Mivtachim Insurance Ltd. | Insurance Company | 2.3779 | 26641218 | 3376658 | 2023-03-31 | LOW |
| Migdal Insurance and Financial Holdings Ltd | Insurance Company | 2.0838 | 23346560 | 1750000 | 2023-03-31 | HIGH |
| Harel Insurance Investments and Financial Services Ltd | Investment Advisor | 2.0795 | 23298179 | 8179950 | 2023-03-31 | LOW |
| Phoenix Investment and Finances Ltd | Investment Advisor | 1.9756 | 22133802 | -24749 | 2023-03-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.7463 | 19564828 | 4441883 | 2023-03-31 | LOW |
| Clal Insurance Enterprises Holdings Ltd. | Investment Advisor | 1.6812 | 18835666 | 406000 | 2023-03-31 | LOW |
| EXOR Investments (UK) LLP | Investment Advisor | 1.5256 | 17091910 | 2083521 | 2023-03-31 | MED |
| Capital International Investors | Investment Advisor | 0.891 | 9982828 | -694512 | 2023-03-31 | LOW |
| Citadel Advisors LLC | Hedge Fund | 0.8525 | 9551351 | 6879779 | 2023-03-31 | HIGH |
| Abrams Capital, L.L.C. | Hedge Fund | 0.7111 | 7966433 | -7966432 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6027 | 6752562 | 207161 | 2023-03-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.5833 | 6534660 | 1944097 | 2023-03-31 | HIGH |
| Millennium Management LLC | Hedge Fund | 0.5529 | 6194846 | 5158012 | 2023-03-31 | HIGH |
| Eversept Partners, LP | Hedge Fund | 0.5529 | 6194572 | 1481975 | 2023-03-31 | HIGH |
| BSN Capital Partners Ltd | Investment Advisor | 0.5355 | 6000000 | 6000000 | 2022-12-31 | HIGH |
| Beck, Mack & Oliver LLC | Investment Advisor | 0.5084 | 5695658 | -668675 | 2023-03-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group535K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$113M+
Mesečni obseg naložb
$64M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Teva Company profile
O družbi Teva Pharma Ind Adr Rep 1
Teva Pharmaceutical Industries Ltd je farmacevtsko podjetje s sedežem v Izraelu. Družba posluje v treh segmentih: Severna Amerika, Evropa in mednarodni trgi. Vsak poslovni segment upravlja celoten portfelj izdelkov v svoji regiji, vključno z generičnimi zdravili, posebnimi izdelki in izdelki brez recepta (OTC). Poleg teh treh segmentov ima družba tudi druge dejavnosti, predvsem prodajo aktivnih farmacevtskih sestavin (API) tretjim osebam, nekatere pogodbene proizvodne storitve in platformo za izdajo licenc, ki prek podružnice Medis ponuja portfelj izdelkov drugim farmacevtskim družbam.
| Industry: | Pharmaceuticals (NEC) |
5 Bazel St
P O B 3190
PETAH TIKVA
49131
IL
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 535.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com